Eltenac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C12H9Cl2NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A153L3JA99, chemically known as 4-(2,6-dichloroanilino)-3-thiopheneacetic acid but generally known as eltenac, which bears US NIH Compound Identifier 51717. European Medicines Agency schedules Eltenac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06495MIG. The term ELTENAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). ELTENAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eltenac under HS 29349990 and SITC 51579. As of Q4 2014, ELTENAC remains the US FDA Preferred Term for this commodity. Eltenac bears US NLM identifiers UMLS ID C0648171 and NCI Concept Code C77358. SMILES: CLC1C(NC2C(CC(=O)O)CSC2)C(CL)CCC1.